These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 922120)

  • 21. Etoposide (VP-16-213).
    Issell BF; Crooke ST
    Cancer Treat Rev; 1979 Jun; 6(2):107-24. PubMed ID: 385138
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinoma.
    D'Incalci M; Erba E; Vaghi M; Morasca L
    Eur J Cancer Clin Oncol; 1982 Apr; 18(4):377-80. PubMed ID: 6889515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.
    Salsbury AJ; Burrage K; Hellmann K
    Cancer Res; 1974 Apr; 34(4):843-9. PubMed ID: 4814997
    [No Abstract]   [Full Text] [Related]  

  • 24. Relative toxicity of methotrexate in several tissues of mice bearing Lewis lung carcinoma.
    Zaharko DS; Dedrick RL; Peale AL; Drake JC; Lutz RJ
    J Pharmacol Exp Ther; 1974 Jun; 189(3):585-92. PubMed ID: 4843162
    [No Abstract]   [Full Text] [Related]  

  • 25. [The antitumor activity of intraperitoneally- or orally-administered etoposide in animals and its administration-schedule dependency].
    Okamoto K; Nishikawa K; Seki T; Shibasaki C; Uchida T; Takahashi K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2331-7. PubMed ID: 4073928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
    Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of actions inhibiting neovascularization of the metastasis of Lewis lung carcinoma].
    Sopotsinskaia EB; Lisniak IA; Balitskiĭ KP
    Eksp Onkol; 1985; 7(5):68-71. PubMed ID: 2415319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Kidney Invasion Test: an assay allowing macroscopic quantification of malignant invasion in vivo. Comparison between the microtubule inhibitor tubulozole and the podophyllotoxin congener etoposide (VP-16-213).
    Distelmans W; Van Ginckel R; Vanherck W; De Brabander M
    Invasion Metastasis; 1985; 5(3):170-84. PubMed ID: 3997412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antitumor activity by long-term administration of low-dose etoposide].
    Kusama K; Ekimoto H; Ishii T; Okamoto K; Takahashi K
    Gan To Kagaku Ryoho; 1991 May; 18(6):959-63. PubMed ID: 2029199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose etoposide (VP-16) in small-cell lung cancer.
    Greco FA; Johnson DH; Hande KR; Porter LL; Hainsworth JD; Wolff SN
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):42-4. PubMed ID: 2983434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor and antimetastatic effects of benzenoid triazenes in mice bearing Lewis lung carcinoma.
    Giraldi T; Guarino AM; Nisi C; Sava G
    Pharmacol Res Commun; 1980 Jan; 12(1):1-11. PubMed ID: 7384159
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II trial of etoposide in previously treated small cell carcinoma of the lung.
    Antman K; Pomfret E; Karp G; Skarin A; Canellos G
    Cancer Treat Rep; 1984 Nov; 68(11):1413-4. PubMed ID: 6094004
    [No Abstract]   [Full Text] [Related]  

  • 33. Action of free radical in podophyllic acid piperindyl hydrazone nitroxide radical on its antitumor activity and toxicity.
    Jia ZP; Wang R; Xie JW; Xu LT
    Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):571-6. PubMed ID: 10678157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of angiostatic steroid with or without glucocorticoid activity on metastasis.
    Sakamoto N; Tanaka NG
    Invasion Metastasis; 1987; 7(4):208-16. PubMed ID: 2444551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different metastatic potential of in vitro and in vivo lines selected from Lewis lung carcinoma: correlation with response to different bleomycin schedulings.
    Sacchi A; Calabresi F; Greco C; Zupi G
    Invasion Metastasis; 1981; 1(4):227-38. PubMed ID: 6203864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between VP 16 and VM 26 in Lewis lung carcinoma of the mouse.
    Colombo T; Broggini M; Vaghi M; Amato G; Erba E; D'Incalci M
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):173-9. PubMed ID: 3699080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does etoposide have curative potential?
    Ignoffo RJ
    Clin Pharm; 1983; 2(2):167. PubMed ID: 6309470
    [No Abstract]   [Full Text] [Related]  

  • 38. Etoposide infusions for treatment of metastatic lung cancer.
    Steward WP; Thatcher N; Edmundson JM; Shiu W; Wilkinson PM
    Cancer Treat Rep; 1984 Jun; 68(6):897-9. PubMed ID: 6329509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
    Kado M; Oshima S; Matsui Y; Shimokata K; Hara K; Kanda T; Shima K; Takenaka S
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etoposide in small cell lung cancer resistant to prior chemotherapy.
    Asbury RF; Rubins J; Bennett JM
    Cancer Treat Rep; 1983 Oct; 67(10):951-2. PubMed ID: 6313187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.